Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Albrecht

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Dermatology|February 22, 2021
Pembrolizumab-induced reactivation of bullous pemphigoidSubuhi Kaul, Allison Wang, Solomiya Grushchak, et al.
The British Journal of Dermatology|April 18, 2024
Hidradenitis suppurativa (HS), systemic inflammatory response syndrome and sepsis, sepsis caused by HS: an empty systematic reviewIbrahim Maghari, Homer Abiad, Tina Griffin, et al.
The British Journal of Dermatology|May 23, 2024
Hidradenitis suppurativa, systemic inflammatory response syndrome and sepsis: a database studyEdigin Ehizogie, Ibrahim Maghari, Serigne Lo, et al.
Archives of Dermatology|January 18, 2006
Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapyRosemarie H Liu, Joerg Albrecht, Victoria P Werth
Archives of Dermatology|June 22, 2005
Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisMichael R Heaphy, Joerg Albrecht, Victoria P Werth
Journal of the American Academy of Dermatology|August 2, 2020
Viability considerations in implementing same-class topical steroid substitutionHarrison P Nguyen, John S Barbieri, Joerg Albrecht
JAAD Case Reports|June 13, 2025
Hemorrhagic bullae on bilateral lower extremitiesMeenakshi Manivannan, Damilola Oladinni, Vesna Petronic-Rosic, et al.
JAAD Case Reports|June 20, 2025
Angioinvasive Scopulariopsis infectionMeenakshi Manivannan, Damilola Oladinni, Vesna Petronic-Rosic, et al.
JAMA Dermatology|August 11, 2021
Racial and Ethnic Distribution of Patients Hospitalized With Hidradenitis Suppurativa, 2008-2018Ehizogie Edigin, Subuhi Kaul, Precious Obehi Eseaton, et al.
Journal of the American Academy of Dermatology|July 27, 2021
At 180 days hidradenitis suppurativa readmission rate is comparable to heart failure: Analysis of the nationwide readmissions databaseEhizogie Edigin, Subuhi Kaul, Precious Obehi Eseaton, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Dermatology|February 22, 2021
Pembrolizumab-induced reactivation of bullous pemphigoidSubuhi Kaul, Allison Wang, Solomiya Grushchak, et al.
The British Journal of Dermatology|April 18, 2024
Hidradenitis suppurativa (HS), systemic inflammatory response syndrome and sepsis, sepsis caused by HS: an empty systematic reviewIbrahim Maghari, Homer Abiad, Tina Griffin, et al.
The British Journal of Dermatology|May 23, 2024
Hidradenitis suppurativa, systemic inflammatory response syndrome and sepsis: a database studyEdigin Ehizogie, Ibrahim Maghari, Serigne Lo, et al.
Archives of Dermatology|January 18, 2006
Cross-sectional study of bisphosphonate use in dermatology patients receiving long-term oral corticosteroid therapyRosemarie H Liu, Joerg Albrecht, Victoria P Werth
Archives of Dermatology|June 22, 2005
Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgarisMichael R Heaphy, Joerg Albrecht, Victoria P Werth
Journal of the American Academy of Dermatology|August 2, 2020
Viability considerations in implementing same-class topical steroid substitutionHarrison P Nguyen, John S Barbieri, Joerg Albrecht
JAAD Case Reports|June 13, 2025
Hemorrhagic bullae on bilateral lower extremitiesMeenakshi Manivannan, Damilola Oladinni, Vesna Petronic-Rosic, et al.
JAAD Case Reports|June 20, 2025
Angioinvasive Scopulariopsis infectionMeenakshi Manivannan, Damilola Oladinni, Vesna Petronic-Rosic, et al.
JAMA Dermatology|August 11, 2021
Racial and Ethnic Distribution of Patients Hospitalized With Hidradenitis Suppurativa, 2008-2018Ehizogie Edigin, Subuhi Kaul, Precious Obehi Eseaton, et al.
Journal of the American Academy of Dermatology|July 27, 2021
At 180 days hidradenitis suppurativa readmission rate is comparable to heart failure: Analysis of the nationwide readmissions databaseEhizogie Edigin, Subuhi Kaul, Precious Obehi Eseaton, et al.
Pageof 5